Neuberger Berman Group LLC Sells 188,123 Shares of Envision Healthcare Co. (EVHC)

Neuberger Berman Group LLC reduced its holdings in shares of Envision Healthcare Co. (NYSE:EVHC) by 32.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 391,470 shares of the company’s stock after selling 188,123 shares during the quarter. Neuberger Berman Group LLC owned approximately 0.32% of Envision Healthcare worth $17,597,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also bought and sold shares of the company. Sawtooth Solutions LLC boosted its stake in shares of Envision Healthcare by 0.7% during the 2nd quarter. Sawtooth Solutions LLC now owns 6,656 shares of the company’s stock worth $417,000 after purchasing an additional 43 shares during the last quarter. Boys Arnold & Co. Inc. boosted its stake in shares of Envision Healthcare by 0.6% during the 2nd quarter. Boys Arnold & Co. Inc. now owns 8,125 shares of the company’s stock worth $509,000 after purchasing an additional 50 shares during the last quarter. PNC Financial Services Group Inc. boosted its stake in shares of Envision Healthcare by 1.5% during the 2nd quarter. PNC Financial Services Group Inc. now owns 4,848 shares of the company’s stock worth $304,000 after purchasing an additional 70 shares during the last quarter. Utah Retirement Systems boosted its stake in shares of Envision Healthcare by 0.5% during the 2nd quarter. Utah Retirement Systems now owns 21,289 shares of the company’s stock worth $1,335,000 after purchasing an additional 100 shares during the last quarter. Finally, M&T Bank Corp boosted its stake in shares of Envision Healthcare by 2.7% during the 2nd quarter. M&T Bank Corp now owns 5,420 shares of the company’s stock worth $341,000 after purchasing an additional 141 shares during the last quarter.

Shares of Envision Healthcare Co. (EVHC) opened at $34.38 on Monday. The company has a debt-to-equity ratio of 0.89, a current ratio of 3.01 and a quick ratio of 3.00. Envision Healthcare Co. has a 12-month low of $23.77 and a 12-month high of $73.00. The stock has a market cap of $4,180.00, a P/E ratio of -23.07, a P/E/G ratio of 1.16 and a beta of 0.57.

Envision Healthcare (NYSE:EVHC) last posted its quarterly earnings results on Tuesday, October 31st. The company reported $0.73 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.81 by ($0.08). Envision Healthcare had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $2.03 billion. During the same quarter in the previous year, the business posted $1.13 EPS. The company’s quarterly revenue was up 142.0% on a year-over-year basis. analysts anticipate that Envision Healthcare Co. will post 2.49 EPS for the current fiscal year.

Envision Healthcare declared that its board has approved a stock buyback plan on Monday, September 18th that allows the company to repurchase $250.00 million in outstanding shares. This repurchase authorization allows the company to buy up to 4.5% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s board believes its stock is undervalued.

EVHC has been the topic of several analyst reports. Bank of America decreased their price target on shares of Envision Healthcare from $72.00 to $60.00 and set a “buy” rating on the stock in a research note on Monday, October 9th. SunTrust Banks set a $55.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research report on Sunday, October 15th. Robert W. Baird reissued a “buy” rating and issued a $70.00 target price on shares of Envision Healthcare in a research report on Tuesday, October 17th. Cantor Fitzgerald cut shares of Envision Healthcare from an “overweight” rating to a “neutral” rating and set a $30.00 target price on the stock. in a research report on Wednesday, November 1st. Finally, Jefferies Group set a $71.00 target price on shares of Envision Healthcare and gave the stock a “buy” rating in a research report on Wednesday, November 1st. One analyst has rated the stock with a sell rating, seven have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company’s stock. Envision Healthcare has an average rating of “Buy” and a consensus target price of $43.25.

TRADEMARK VIOLATION NOTICE: “Neuberger Berman Group LLC Sells 188,123 Shares of Envision Healthcare Co. (EVHC)” was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.com-unik.info/2017/12/25/neuberger-berman-group-llc-sells-188123-shares-of-envision-healthcare-co-evhc.html.

Envision Healthcare Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Want to see what other hedge funds are holding EVHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envision Healthcare Co. (NYSE:EVHC).

Institutional Ownership by Quarter for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit